WebCSL Behring Announces Closing of Global Commercialization and License Agreement with uniQure for etranacogene dezaparvovec • Etranacogene dezaparvovec (AMT-061) is an investigational gene therapy that may potentially provide people with hemophilia B with years of functional levels of Factor IX, a blood-clotting protein that prevents excessive … WebCSL Behring is a specialty biotherapeutics company built on more than a century of service to people with serious medical conditions around the world. Biotherapies differ from …

News Releases CSL

WebVidhi Desai joined CSL Behring in 2024 as Therapeutic Area Head, Director Medical Affairs for Coagulation Products in North America, providing strategic and tactical medical leadership for Idelvion®, Afstyla® and Humate-P®, contributing to key operational and cross-functional projects as a member of the Medical Affairs leadership team. WebCSL Behring equips patients with a broad range of therapeutics in order to treat rare and severe diseases. To receive detailed information to the products available in … small business bell

Product Pipeline CSL Limited

WebAbout CSL Behring CSL Behring is a global leader in developing and delivering high-quality medicines that treat people with rare and serious diseases. Our treatments offer promise for people in more than 100 countries living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. WebCSL Behring is a global leader in developing and delivering high-quality medicines that treat people with rare and serious diseases. Our treatments offer promise for people in more … WebThermo Fisher will support CSL ’ s product portfolio by leveraging its pharma services network, including drug product development, biologics manufacturing, ... CSL – including our two businesses, CSL Behring and Seqirus - provides life-saving products to more than 70 countries and employs more than 26,000 people. Our unique combination of ... small business bed sheets